PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Cytokine-induced killer (CIK) cell immunotherapy represents an effective treatment strategy for treating hepatocellular carcinoma (HCC). However, the therapeutic benefits of CIK cell treatment can be influenced by differences in complex immune microenvironment between patients. Herein, we investigat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Chen, Chang-Long, Pan, Qiu-Zhong, Zhao, Jing-Jing, Wang, Ying, Li, Yong-Qiang, Wang, Qi-Jing, Pan, Ke, Weng, De-Sheng, Jiang, Shan-Shan, Tang, Yan, Zhang, Xiao-Fei, Zhang, Hong-Xia, Zhou, Zi-Qi, Zeng, Yi-Xin, Xia, Jian-Chuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006896/
https://ncbi.nlm.nih.gov/pubmed/27622026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1176653
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller